1.Resin infiltration of deproteinised natural occlusal subsurface lesions improves initial quality of fissure sealing
Kielbassa M ANDREJ ; Ulrich INA ; Schmidl RITA ; Schüller CHRISTOPH ; Frank WILHELM ; Werth D VANESSA
International Journal of Oral Science 2017;9(2):117-124
The aim of this ex vivo study was to evaluate the infiltration capability and rate of microleakage of a low-viscous resin infiltrant combined with a flowable composite resin (RI/CR) when used with deproteinised and etched occlusal subsurface lesions (International Caries Detection and Assessment System code 2). This combined treatment procedure was compared with the exclusive use of flowable composite resin (CR) for fissure sealing. Twenty premolars and 20 molars revealing non-cavitated occlusal carious lesions were randomly divided into two groups and were meticulously cleaned and deproteinised using NaOCl (2%). After etching with HCl (15%), 10 premolar and 10 molar lesions were infiltrated (Icon/DMG; rhodamine B isothiocyanate (RITC)-labelled) followed by fissure sealing (G-?nial Flo/GC; experimental group, RI/CR). In the control group (CR), the carious fissures were only sealed. Specimens were cut perpendicular to the occlusal surface and through the area of the highest demineralisation (DIAGNOdent pen, KaVo). Using confocal laser-scanning microscopy, the specimens were assessed with regard to the percentage of caries infiltration, marginal adaption and internal integrity. Within the CR group, the carious lesions were not infiltrated. Both premolar (57.9%± 23.1%) and molar lesions (35.3%± 22.1%) of the RI/CR group were uniformly infiltrated to a substantial extent, albeit with significant differences (P=0.034). Moreover, microleakage (n=1) and the occurrence of voids (n=2) were reduced in the RI/CR group compared with the CR group (5 and 17 specimens, respectively). The RI/CR approach increases the initial quality of fissure sealing and is recommended for the clinical control of occlusal caries.
2.Whither systems medicine?
Rolf APWEILER ; Tim BEISSBARTH ; Michael R BERTHOLD ; Nils BLüTHGEN ; Yvonne BURMEISTER ; Olaf DAMMANN ; Andreas DEUTSCH ; Friedrich FEUERHAKE ; Andre FRANKE ; Jan HASENAUER ; Steve HOFFMANN ; Thomas HöFER ; Peter LM JANSEN ; Lars KADERALI ; Ursula KLINGMüLLER ; Ina KOCH ; Oliver KOHLBACHER ; Lars KUEPFER ; Frank LAMMERT ; Dieter MAIER ; Nico PFEIFER ; Nicole RADDE ; Markus REHM ; Ingo ROEDER ; Julio SAEZ-RODRIGUEZ ; Ulrich SAX ; Bernd SCHMECK ; Andreas SCHUPPERT ; Bernd SEILHEIMER ; Fabian J THEIS ; Julio VERA ; Olaf WOLKENHAUER
Experimental & Molecular Medicine 2018;50(3):e453-
New technologies to generate, store and retrieve medical and research data are inducing a rapid change in clinical and translational research and health care. Systems medicine is the interdisciplinary approach wherein physicians and clinical investigators team up with experts from biology, biostatistics, informatics, mathematics and computational modeling to develop methods to use new and stored data to the benefit of the patient. We here provide a critical assessment of the opportunities and challenges arising out of systems approaches in medicine and from this provide a definition of what systems medicine entails. Based on our analysis of current developments in medicine and healthcare and associated research needs, we emphasize the role of systems medicine as a multilevel and multidisciplinary methodological framework for informed data acquisition and interdisciplinary data analysis to extract previously inaccessible knowledge for the benefit of patients.